BlackRock’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.7M Buy
1,734,151
+1,323,026
+322% +$15.8M ﹤0.01% 2961
2025
Q1
$4.89M Buy
411,125
+17,862
+5% +$212K ﹤0.01% 3616
2024
Q4
$6.05M Buy
393,263
+21,662
+6% +$333K ﹤0.01% 3599
2024
Q3
$4.17M Buy
371,601
+5,203
+1% +$58.3K ﹤0.01% 3722
2024
Q2
$1.97M Sell
366,398
-1,107,575
-75% -$5.97M ﹤0.01% 3920
2024
Q1
$10M Buy
1,473,973
+3,917
+0.3% +$26.6K ﹤0.01% 3296
2023
Q4
$9.98M Buy
1,470,056
+105,822
+8% +$719K ﹤0.01% 3329
2023
Q3
$6.83M Sell
1,364,234
-9,542
-0.7% -$47.8K ﹤0.01% 3474
2023
Q2
$9.95M Buy
1,373,776
+962,892
+234% +$6.97M ﹤0.01% 3352
2023
Q1
$3.47M Sell
410,884
-1,858
-0.5% -$15.7K ﹤0.01% 3719
2022
Q4
$3.5M Sell
412,742
-78
-0% -$661 ﹤0.01% 3817
2022
Q3
$4.28M Buy
412,820
+115,127
+39% +$1.19M ﹤0.01% 3743
2022
Q2
$3.88M Sell
297,693
-872,160
-75% -$11.4M ﹤0.01% 3859
2022
Q1
$12.2M Sell
1,169,853
-6,502
-0.6% -$67.7K ﹤0.01% 3396
2021
Q4
$13.2M Buy
1,176,355
+12,783
+1% +$143K ﹤0.01% 3447
2021
Q3
$20.7M Buy
1,163,572
+14,362
+1% +$255K ﹤0.01% 3200
2021
Q2
$21.9M Buy
1,149,210
+829,123
+259% +$15.8M ﹤0.01% 3185
2021
Q1
$6.77M Buy
320,087
+272,022
+566% +$5.75M ﹤0.01% 3739
2020
Q4
$763K Sell
48,065
-1,335
-3% -$21.2K ﹤0.01% 4198
2020
Q3
$270K Sell
49,400
-472
-0.9% -$2.58K ﹤0.01% 4252
2020
Q2
$177K Buy
49,872
+41,529
+498% +$147K ﹤0.01% 4303
2020
Q1
$30K Buy
8,343
+570
+7% +$2.05K ﹤0.01% 4480
2019
Q4
$37K Buy
+7,773
New +$37K ﹤0.01% 4514